A strategic competitor is offering two turns of EBITDA higher than a private equity recapitalization offer, but half the premium is tied to post-integration synergy milestones. How do we calculate the risk-adjusted value of that strategic spread?

Question

Tyler Smith · Accepted Answer

Headline valuation is irrelevant if the mechanisms to capture it are outside your control. A strategic buyer offering an eight-times multiple with two turns locked in post-close synergy milestones often delivers lower net proceeds than a financial sponsor offering a clean six times with ninety percent cash at close.

Start by assessing operational control. In a strategic acquisition, the buyer typically merges sales teams, consolidates software platforms, and centralizes administrative functions. Once they integrate operations, tracking standalone revenue or cost savings becomes nearly impossible. If synergy milestones depend on their team executing cross-selling initiatives, your payout is hostage to their internal competence.

Next, apply a discount rate to contingent milestones. Historical M&A data shows that earnouts and post-close synergy targets pay out at less than fifty percent of headline value. Discount that conditional tranche by at least fifty to sixty percent when comparing offers. If the strategic buyer's cash-at-close does not exceed or match the financial sponsor's total cash payout, the strategic offer carries higher risk for comparable return.

Evaluate the non-financial terms. A private equity sponsor typically leaves the existing management team and Accountability Chart intact to run the platform, giving you influence over performance. The strategic buyer may terminate redundant staff and eliminate brand equity.

If you prefer the strategic buyer, renegotiate the contingent portion into an unconditional seller note or demand that synergy targets be tied to top-line consolidated metrics rather than complex cost-allocation formulas. Never trade certainty at close for unachievable corporate synergies.